Argent Capital Management’s Orthofix Medical OFIX Stock Holding History

Argent Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-64,805	Closed	-$3.4M	–	202
2018 Q4	$3.4M	Sell	64,805 -125	-0.2%	-$7.11K	0.17%	65
2018 Q3	$3.75M	Hold	64,930	–	–	0.13%	81
2018 Q2	$3.69M	Buy	64,930 +1,450	+2%	+$82.6K	0.13%	82
2018 Q1	$3.73M	Buy	63,480 +10,875	+21%	+$609K	0.14%	73
2017 Q4	$3.02M	Buy	+52,605	New	+$2.73M	0.1%	93

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Argent Capital Management's OFIX Position: Q1 2019 in Review

Argent Capital Management sold out of Orthofix Medical (OFIX) in Q1 2019, closing a stake of 64,805 shares — an estimated $3.4M sold.

Argent Capital Management first reported a position in OFIX in Q4 2017 and held it in 5 quarters. The position peaked at $3.75M in Q3 2018. 172 funds tracked by Wall St. Rank hold OFIX as of Q1 2019.

Argent Capital Management reported no remaining Orthofix Medical position as of Q1 2019 after selling out during the quarter.
Argent Capital Management sold 64,805 Orthofix Medical shares in Q1 2019, an estimated $3.4M.
Argent Capital Management first reported a position in Orthofix Medical in Q4 2017 and held it in 5 quarters.
Argent Capital Management's Orthofix Medical position peaked at $3.75M in Q3 2018.
172 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2019.

Based on Argent Capital Management's 13F filing for Q1 2019, filed 10 May 2019.